Oncogenic osteomalacia

Skeletal Radiology

Volumn 29, Issue 3, 2000, Pages 117-124

  Sundaram, M ^a   McCarthy, E F ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Fibrohistiocytic tumors; Hemangiopericytoma; Metabolic disease; MRI; Osteomalacia; Radiography

Indexed keywords

CALCITRIOL; PHOSPHATE;

BONE CANCER; HUMAN; OSTEOMALACIA; PARANEOPLASTIC SYNDROME; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; X RAY;

EID: 0034116264     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002560050581     Document Type: Review

References (36)

1. Prader VA, Illig R, Vehlinger E, Stalder G. Rachitis, Infolge, Knochen Tumors. Helv Pediatr Acta 1959;14:554-565.
2. Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby, 1998: 1111-1119.
3. Camus JP, Crouzet J, Prier A, Guillemant S, Ulmann A, Koeger AC. Osteomalacies hypophosphoremiques guéries par l'ablation de tumeurs benignes du tisu conjonctif. Ann Med Intern (Paris) 1980; 131:422-426.
4. Furuya K, Isobe Y, Morita M. Hypertrophic osteoarthropathy and hypophosphatemic osteomalacia associated with tumor. Gan To Kajaku Ryoho 1986; 13:2056-2064.
5. Gitelis S, Ryan WJ, Rosenberg AG, Templeton AC. Adult-onset hypophosphatemic osteomalacia secondary to neoplasm. J Bone Joint Surg Am 1986; 68:134-138.
6. McClure J, Smith PS. Oncogenic osteomalacia. J Clin Pathol 1987; 40:446-453
7. Renton P, Shaw DG. Hypophosphatemic osteomalacia secondary to vascular tumors of bone and soft tissue. Skeletal Radiol 1976; 1:21-24.
8. Seshadri MS, Cornish CJ, Mason RS, Posen S. Parathyroid hormone-like bioactivity in tumors from patients with oncogenic osteomalacia. Clin Endocrinol 1985; 23:689-697.
9. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. Cancer 1987; 59:1442-1454.
10. Pollack JA, Schiller AL, Crawford JD. Rickets and myopathy cured by removal of a non-ossifying fibroma of bone. Pediatrics 1973;52:364-371.
11. Martini A, Notarangelo LD, Barberis L, Galvanini G, Burgio, Lanzi G. Acquired vitamin-D resistant rickets caused by prolonged latency in appearance of bone tumor. Am J Dis Child 1983; 137:1025-1026.
12. Sparagana M. Tumor-induced osteomalacia: long-term follow up of two patients cured by removal of their tumors. J Surg Oncol 1987;36:198-205.
13. Nomura G, Koshino Y, Morimoto H, Kida H, Nomura S, Tamai K. Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case. Jpn J Med 1981; 21:35-39.
14. Park YK, Unni KK, Beabout JW, Hodgson SF. Oncogenic osteomalacia: a clinicopathologic study of 17 bone lesions. J Korean Med Sci 1994; 9:289-298.
15. Wyman AL, Paratinas FJ, Daly JR. Hypophosphatemic osteomalacia associated with a malignant tumor of the tibia: report of a case. J Clin Pathol 1997; 30:328-335.
16. Sparagana M. Tumor-induced osteomalacia: long-term follow up of two patients cured by removal of their tumors. J Surg Oncol 1987; 36:198-205.
17. Castleman B, McNeely BU. Case records of the Massachusetts General Hospital. N Engl J Med 1965; 273:494-504.
18. Hasegawa T, Shimoda T, Yokoyama R, Beppu Y, Hirohashi S, Maeda S, Intracortical osteoblastic osteosarcoma with oncogenic rickets. Skeletal Radiol 1999; 28:41-45.
19. Ohashi K, Ohnishi T, Ishikawa T, Tani H, Uesugi K, Takagi M, Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia. Skeletal Radiol 1999; 28:46-49.
20. Avila NA, Skarulis M, Rubino DM, Doppman JL. Oncogenic osteomalacia: lesion detection by MR skeletal survey. AJR 1996; 167:343-345.
21. Drezner MK. Tumor-induced rickets and osteomalacia. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. New York: Raven Press, 1996: 319-325.
22. Aschinberg LC, Solomon LM, Zeis PM, Justice P, Rosenthal IM. Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J Pediatr 1977; 91:56-60.
23. Lau K, Stom MC, Goldberg M, Goldfarb S, Gray RW, Lemann J. Agus ZS. Evidence for a humoral phosphaturic factor in oncogenic hypophosphatemic osteomalacia (abstract). Clin Res 1979; 27:421A.
24. Popovtzer MM. Tumor-induced hypophopsphatemic osteomalacia (TUO): evidence for a phosphaturic cyclic AMP-independent action of tumor extract (abstract). Clin Res 1981; 29:418A.
25. Miyauchi A, Fukase M, Tsutsumi M, Fujita T. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. J Clin Endocrinol Metab 1988; 67:46-53.
26. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 1994; 330:1645-1649.
27. Econs MJ, Drezner MK. Tumor-induced osteomalacia: unveiling a new hormone [editorial: comment]. N Engl J Med 1994; 330:1679-1681.
28. Nelson AE, Namkung HJ, Patava J, Wilkinson MR, Chang ACM, Reddel RR, Robinson BG, Mason RS. Characteristics of tumor cell bioactivity in oncogenic osteomalacia. Mol Cell Endocrinol 1996; 124:17-23.
29. Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 1995; 80:1628-1634.
30. Meyer RAJR, Meyer MH, Gray RW. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Miner Res 1989; 4:493-500.
31. Nelson AE, Robinson BG, Mason RS. Oncogenic osteomalacia: is there a new phosphate regulating hormone? Clin Endocrinol 1997; 47:635-642.
32. The HYP Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet 1995; 11:130-136.
33. Holm IA, Huang X, Kunkel LM. Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet 1997; 60:790-797.
34. Nelson AE, Mason RS, Robinson BG. The PEX gene: not a simple answer for X-linked hypophosphataemic rickets and oncogenic osteomalacia. Mol Cell Endocrinol 1997; 132:1-5.
35. Nesbitt T, Drezner MK. Hepatocyte production of phosphatonin in HYP mice. J Bone Miner Res 1996 (Suppl 1):S136.
36. Kumar R. Divalent-ion metabolism and its regulation. In: Jacobson HR, Striker GE. Klahr S (eds) The principles and practice of nephrology. St Louis: Mosby, 1995:964-971.